Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 2, Issue 9
1 September 2003
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma
Masood A. Shammas; Robert J. Shmookler Reis; Masaharu Akiyama; Hemanta Koley; Dharminder Chauhan; Teru Hideshima; Raj K. Goyal; Laurence H. Hurley; Kenneth C. Anderson; Nikhil C. Munshi
View articletitled, Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma
Open the PDF for in another window
Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts
Simon Williams; Curtis Pettaway; Rendu Song; Christos Papandreou; Christopher Logothetis; David J. McConkey
View articletitled, Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts
Open the PDF for in another window
Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay
Gordon R. Macpherson; Sylvia S.W. Ng; Siiri L. Forbes; Giovanni Melillo; Tatiana Karpova; James McNally; Thomas P. Conrads; Timothy D. Veenstra; Alfredo Martinez; Frank Cuttitta; Douglas K. Price; William D. Figg
View articletitled, Anti-angiogenic activity of human endostatin is HIF-1-independent <em>in vitro</em> and sensitive to timing of treatment in a human saphenous vein assay
Open the PDF for in another window
PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy
John M. Fidler; Ke Li; Cathie Chung; Ke Wei; Jessica A. Ross; Mingxing Gao; Glenn D. Rosen
View articletitled, PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy
Open the PDF for in another window
Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells
Yajaira Suárez; Laura González; Ana Cuadrado; Maite Berciano; Miguel Lafarga; Alberto Muñoz
View articletitled, Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells
Open the PDF for in another window
MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo
Deepak Sampath; Carolyn M. Discafani; Frank Loganzo; Carl Beyer; Hao Liu; Xingzhi Tan; Sylvia Musto; Tami Annable; Patricia Gallagher; Carol Rios; Lee M. Greenberger
View articletitled, MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel <em>in vitro</em> and <em>in vivo</em>
Open the PDF for in another window
Sulindac metabolites induce caspase- and proteasome-dependent degradation of β-catenin protein in human colon cancer cells
Pamela L. Rice; Jennifer Kelloff; Holly Sullivan; Linda J. Driggers; K. Scott Beard; Scott Kuwada; Gary Piazza; Dennis J. Ahnen
View articletitled, Sulindac metabolites induce caspase- and proteasome-dependent degradation of β-catenin protein in human colon cancer cells
Open the PDF for in another window
Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells
Juan C. Acosta; Carlos Richard; M. Dolores Delgado; Machiko Horita; M. Giulia Rizzo; Jose L. Fernández-Luna; Javier León
View articletitled, Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells
Open the PDF for in another window
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts
Rachel L. Cowen; Adam V. Patterson; Brian A. Telfer; Rachel E. Airley; Steve Hobbs; Roger M. Phillips; Mohammed Jaffar; Ian J. Stratford; Kaye J. Williams
View articletitled, Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts
Open the PDF for in another window
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines
Hiroaki Goto; Bo Yang; Denise Petersen; Karen A. Pepper; Paul A. Alfaro; Donald B. Kohn; C. Patrick Reynolds
View articletitled, Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines
Open the PDF for in another window
Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies
Robert A. Gatenby; Thomas L. Vincent
View articletitled, Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies
Open the PDF for in another window

Meeting Report

Preclinical models for defining efficacy of drug combinations: mapping the road to the clinic
Miriam S. Gitler; Anne Monks; Edward A. Sausville
View articletitled, Preclinical models for defining efficacy of drug combinations: mapping the road to the clinic
Open the PDF for in another window

Advertisement

Breaking
Tafasitamab Lowers Risk of Follicular Lymphoma Progression
9/11 First Responders Have Twofold Increase in Leukemia Precursor
Daratumumab Can Prevent Progression of Myeloma Precursor
View more recent articles
Latest News
Imlunestrant Delays Progression in Some Breast Cancers
“Digital Twins” May Improve Treatment Prediction
Prevention and Screening Preclude 80% of Cancer Deaths
View more recent articles
Research Watch
The Liver X Receptor Axis Balances Intestinal Regeneration and Tumorigenesis
Oncolytic Virotherapy Plus Nivolumab Is Safe in Muscle-Invasive Bladder Cancer
Specialized Fibroblasts Shape T-Cell Environments in Lung Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept